Items where Author is "Miller, Keith"

BERTELSEN, Magnus, LACEY, Melissa, NICHOL, Tim and MILLER, Keith (2023). Mechanistic Insight into the Early Stages of Toroidal Pore Formation by the Antimicrobial Peptide Smp24. Pharmaceutics, 15 (10): 2399. [Article]

RAWSON, Kirstie M., LACEY, Melissa M., STRONG, Peter N. and MILLER, Keith (2022). Improving the therapeutic index of Smp24, a venom-derived antimicrobial peptide: increased activity against gram-negative bacteria. International Journal of Molecular Sciences, 23 (14): 7979. [Article]

ELRAYESS, Ranwa A., MOHALLAL, Mahmoud E., MOBARAK, Yomn M., EBAID, Hala M., HAYWOOD-SMALL, Sarah, MILLER, Keith, STRONG, Peter and ABDEL-RAHMAN, Mohamed A. (2022). Scorpion Venom Antimicrobial Peptides Induce Caspase-1 Dependant Pyroptotic Cell Death. Frontiers in Pharmacology, 12. [Article]

KHAN, Muhammad, MILLER, Keith, RAWSON, Kirstie and ZHOU, Yong (2021). Synthesis and In Vitro Anti-Helicobacter and Anti-Staphylococcal Activities of Novel Diaryldisulfides and Diarylthiosulfonates. Advances in Biological Chemistry, 11 (5), 251-265. [Article]

TAWFIK, Mohamed M., BERTELSEN, Magnus, ABDEL-RAHMAN, Mohamed A., STRONG, Peter N. and MILLER, Keith (2021). Scorpion Venom Antimicrobial Peptides Induce Siderophore Biosynthesis and Oxidative Stress Responses in Escherichia coli. mSphere, 6 (3). [Article]

ELRAYESS, Ranwa A., MOHALLAL, Mahmoud E, EL-SHAHAT, Yomn M, EBAID, Hala M, MILLER, Keith, STRONG, Peter and ABDEL-RAHMAN, Mohamed A (2019). Cytotoxic effects of Smp24 and Smp43 scorpion venom antimicrobial peptides on tumour and non-tumour cell lines. International Journal of Peptide Research and Therapeutics, 26 (3), 1409-1415. [Article]

CODJOE, Francis. S., BROWN, Charles A., SMITH, Thomas, MILLER, Keith and DONKOR, Eric S. (2019). Genetic relatedness in carbapenem-resistant isolates from clinical specimens in Ghana using ERIC-PCR technique. PLoS One, 14 (9), e0222168. [Article]

CODJOE, Francis S., DONKOR, Eric S., SMITH, Thomas and MILLER, Keith (2019). Phenotypic and genotypic characterization of carbapenem-resistant gram-negative bacilli pathogens from hospitals in Ghana. Microbial drug resist. [Article]

BAO, Peng, PATERSON, Daniel A., HARRISON, Patrick L., MILLER, Keith, PEYMAN, Sally, JONES, J. Cliff, SANDOE, Jonathan, EVANS, Stephen D., BUSHBY, Richard J. and GLEESON, Helen F. (2019). Lipid coated liquid crystal droplets for the on-chip detection of antimicrobial peptides. Lab on a chip, 19 (6), 1082-1089. [Article]

HEATH, George R., HARRISON, Patrick, STRONG, Peter, EVANS, Stephen D. and MILLER, Keith (2018). Visualization of diffusion limited antimicrobial peptide attack on supported lipid membranes. Soft Matter, 14 (29), 6146-6154. [Article]

CHIRILA, Paula, SKIBINSKI, Lauren, MILLER, Keith, HAMILTON, Alexander and WHITEOAK, Christopher (2018). Towards a Sequential One-Pot Preparation of 1,2,3-Benzotriazin-4(3H)-ones Employing a Key Cp*Co(III)-catalyzed C-H Amidation Step. Advanced Synthesis & Catalysis, 360 (12), 2324-2332. [Article]

LIU, Gaomin, YANG, Fan, LI, Fangfang, LI, Zhongjie, LANG, Yange, SHEN, Bingzheng, WU, Yingliang, LI, Wenxin, HARRISON, Patrick L., STRONG, Peter N., XIE, Yingqiu, MILLER, Keith and CAO, Zhijian (2018). Therapeutic potential of a scorpion venom-derived antimicrobial peptide and its homologs against antibiotic-resistant gram-positive bacteria. Frontiers in Microbiology, 9, p. 1159. [Article]

HARRISON, Patrick L., ABDEL-RAHMAN, Mohamed A., STRONG, Peter, TAWFIK, Mohamed M. and MILLER, Keith (2016). Characterisation of three alpha-helical antimicrobial peptides from the venom of Scorpio maurus palmatus. Toxicon, 117, 30-36. [Article]

HARRISON, Patrick L., HEATH, George R., JOHNSON, Benjamin R.G., ABDEL-RAHMAN, Mohamed A., STRONG, Peter, EVANS, Stephen D. and MILLER, Keith (2016). Phospholipid dependent mechanism of smp24, an α-helical antimicrobial peptide from scorpion venom. Biochimica et Biophysica Acta (BBA) - Biomembranes, 1858 (11), 2737-2744. [Article]

HARRISON, Patrick L, ABDEL-RAHMAN, Mohamed, MILLER, Keith and STRONG, Peter (2014). Antimicrobial peptides from scorpion venoms. Toxicon, 88, 115-137. [Article]

KHAN, Akram, MILLER, Keith, RAINSFORD, Kim and ZHOU, Yong (2013). Synthesis and Antimicrobial Activity of Novel Substituted Ethyl 2-(Quinolin-4-yl)-propanoates. Molecules, 18 (3), 3227-3240. [Article]

KHAN, M., MILLER, Keith, RAINSFORD, Kim and ZHOU, Yong (2013). Synthesis and antimicrobial activity of novel substituted Ethyl 2-(Quinolin-4-yl)-propanoates. Molecules, 18 (3), 3227-3240. [Article]

MARINER, K R, TROWBRIDGE, R, AGARWAL, A K, MILLER, Keith, O'NEILL, A J, FISHWICK, C W and CHOPRA, I (2010). Furanyl-rhodanines are unattractive drug candidates for development as inhibitors of bacterial RNA polymerase. Antimicrobial Agents and Chemotherapy, 54 (10), 4506-4509. [Article]

OOI, N, MILLER, Keith, RANDALL, C, RHYS-WILLIAMS, W, LOVE, W and CHOPRA, I (2010). XF-70 and XF-73, novel antibacterial agents active against slow-growing and non-dividing cultures of Staphylococcus aureus including biofilms. Journal of Antimicrobial Chemotherapy, 65 (1), 72-78. [Article]

HOBBS, J K, MILLER, Keith, O'NEILL, A J and CHOPRA, I (2008). Consequences of daptomycin-mediated membrane damage in Staphylococcus aureus. Journal of Antimicrobial Chemotherapy, 62 (5), 1003-1008. [Article]

DRIFFIELD, K, MILLER, Keith, BOSTOCK, J M, O'NEILL, A J and CHOPRA, I (2008). Increased mutability of Pseudomonas aeruginosa in biofilms. Journal of Antimicrobial Chemotherapy, 61 (5), 1053-1056. [Article]

CHOPRA, I, SCHOFIELD, C, EVERETT, M, ONEILL, A, MILLER, Keith, WILCOX, M, FRERE, J, DAWSON, M, CZAPLEWSKI, L, URLEB, U and COURVALIN, P (2008). Treatment of health-care-associated infections caused by Gram-negative bacteria: a consensus statement. The Lancet Infectious Diseases, 8 (2), 133-139. [Article]

DRIFFIELD, Kiersten L, BOSTOCK, Julieanne M, MILLER, Keith, O'NEILL, Alexander J, HOBBS, Joanne K and CHOPRA, Ian (2006). Evolution of extended-spectrum β-lactamases in a MutS-deficient Pseudomonas aeruginosa hypermutator. The Journal of antimicrobial chemotherapy, 58 (4), 905-907. [Article]

MILLER, Keith, STOREY, Christopher, STUBBINGS, William J, HOYLE, Anthony M, HOBBS, Joanne K and CHOPRA, Ian (2005). Antistaphylococcal activity of the novel cephalosporin CB-181963 (CAB-175). The Journal of antimicrobial chemotherapy, 55 (4), 579-582. [Article]

MILLER, Keith, O'NEILL, Alexander John and CHOPRA, Ian (2004). Escherichia coli mutators present an enhanced risk for emergence of antibiotic resistance during urinary tract infections. Antimicrobial agents and chemotherapy, 48 (1), 23-29. [Article]

CHOPRA, Ian, O'NEILL, Alexander J and MILLER, Keith (2003). The role of mutators in the emergence of antibiotic-resistant bacteria. Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy, 6 (3), 137-145. [Article]

MILLER, Keith, O'NEILL, Alexander John and CHOPRA, Ian (2002). Response of Escherichia coli hypermutators to selection pressure with antimicrobial agents from different classes. The Journal of antimicrobial chemotherapy, 49 (6), 925-934. [Article]